Despite slowdown in COVID, Pfizer promises growthBusiness, R&D, TherapeuticsPfizer forecasted stable growth in the coming years, driven by a strong product push to cushion its non-COVID business and exclusivity losses, according to company chairman and Chief Executive Officer Albert Bourla, M.D., Monday. Read more January 10, 2023/by BioSpace https://www.pharmalive.com/wp-content/uploads/2021/05/Pfizer-Commits-to-Bridging-the-Diversity-Gap-in-Clinical-Trials-BioSpace-5-14-21.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2023-01-10 11:29:552023-01-10 11:29:55Despite slowdown in COVID, Pfizer promises growth